|
|
Volumn 35, Issue 4, 2002, Pages 501-516
|
|
Stability-indicating methods for determination of meloxicam and tenoxicam in the presence of their degradation products
a
|
|
Author keywords
Determination of meloxicam and tenoxicam; Drug formulations; Spectrofluorimetry quenching; Spectrophotometry; Stability indicating method
|
|
Indexed keywords
3 METHYLBENZOTHIAZOLONE HYDRAZONE;
5 METHYL 2 AMINOTHIAZOLE;
BENZOTHIAZINE CARBOXYLIC ACID;
DRUG METABOLITE;
HYDRAZONE DERIVATIVE;
MELOXICAM;
METHYL 4 HYDROXY 2 METHYL 2H THIENO[2,3 E] 1,2 THIAZINE 3 CARBOXYLATE 1,1 DIOXIDE;
NONSTEROID ANTIINFLAMMATORY AGENT;
PYRIDIN 2 AMINE;
TENOXICAM;
UNCLASSIFIED DRUG;
ABSORPTION SPECTROPHOTOMETRY;
ADDITION REACTION;
AEROBIC METABOLISM;
AMPOULE;
ANALYTIC METHOD;
ARTICLE;
DRUG CAPSULE;
DRUG DETERMINATION;
DRUG FORMULATION;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
INFRARED SPECTROMETRY;
POLAROGRAPHY;
SPECTROFLUOROMETRY;
SPECTROPHOTOMETRY;
STATISTICAL SIGNIFICANCE;
TABLET;
VALIDATION PROCESS;
|
|
EID: 0038748435
PISSN: 00387010
EISSN: None
Source Type: Journal
DOI: 10.1081/SL-120013886 Document Type: Article |
|
Times cited : (20)
|
|
References (19)
|
